Crossmark

Hemagglutinin Inhibitors are Potential Future Anti-Influenza Drugs for Mono- and Combination Therapies

Crossref DOI link: https://doi.org/10.1007/978-1-0716-0430-4_48

Published Online: 2020-04-19

Published Print: 2020

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sriwilaijaroen, Nongluk

Suzuki, Yasuo
License Information

Text and Data Mining valid from 2020-01-01

Text and Data Mining valid from 2020-01-01

Version of Record valid from 2020-01-01
More Information

Chapter History

First Online: 19 April 2020

Change Date: 29 September 2020

Change Type: Correction

Change Details: The inadvertently published below contents have been corrected.